2,5-Dimethyl-3-(methyldithio)furan
Common Name: |
2,5-Dimethyl-3-(methyldithio)furan |
IUPAC Name: |
2,5-dimethyl-3-(methyldisulfanyl)furan |
Molecular Formula: |
C14H24OS |
SMILES: |
CC1=CC(=C(O1)C)SSC |
Inchi: |
1S/C7H10OS2/c1-5-4-7(10-9-3)6(2)8-5/h4H,1-3H3 |
Inchi Key: |
ZZXDUGZYDILQMO-UHFFFAOYSA-N |
Cas No: |
61197-06-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
240.40 |
Mass (g/mol) |
174.017 |
Molar Refractivity |
74.35 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
42.37 |
Hetero Atoms |
3 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
45.00 |
Boiling Point (°C@760.00mm Hg) |
284.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.246 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
3.267 |
iLOGP |
3.07 |
XLOGP3 |
3.67 |
WLOGP |
4.22 |
MLOGP |
3.30 |
ESOL Log S |
-3.38 |
ESOL Solubility (mg/ml) |
0.101 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.25 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.96 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.16 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.648 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.41 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |